Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT07235098
Recruiting Not applicable

Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery

NCT07235098 · tracked via the Priya Life Science Switzerland tracker
Phase
Not applicable
Started
2026-06-19
Last updated
2026-07-08

Condition(s) studied

Lung Cancer (Suspected or Confirmed)

Investigational drug(s) / intervention(s)

Music therapy intervention

Music therapy intervention: Patient randomized to experimental Arm A will receive a classical music therapy intervention throughout the duration of their hospital stay for a minimally invasive lung resection.

Study summary

This study aims at evaluating whether music therapy intervention is effective in decreasing psychological (distress) and physical symptoms (pain) in patients with suspected or diagnosed lung cancer undergoing minimally invasive lung surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Suspected or confirmed diagnosis of lung cancer * Age ≥ 18 years * Indication for lung resection through a minimally invasive surgery * Signed written informed consent Exclusion Criteria: * Endocrinological disorders involving cortisol axis * Chronic steroid intake \> 10 mg/day * Concomitant treatment with drugs against symptomatic anxiety and/or depression * Partial or complete hearing loss * Inability to follow the schedule of investigation * Patient unwilling to refrain from actively listening to other music (e.g., via other personal devices/headphones) outside of the prescribed musical intervention defined by the study protocol during the hospitalization.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Oncology Institute of Southern Switzerland (IOSI) Bellinzona Canton Ticino Recruiting

More Oncology Institute of Southern Switzerland trials in Switzerland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07235098 on ClinicalTrials.gov ↗ ← All trials in Switzerland